Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drugs active against hepatitis viruses]

A Goudeau1

  • 1Département de microbiologie médicale et moléculaire, CNRS EP 117, CHU Bretorneau, Tours.

La Revue Du Praticien
|March 15, 1997
PubMed
Summary

Chronic viral hepatitis B, C, and D pose significant public health risks, leading to cirrhosis and liver cancer. Current treatments like interferon alpha show modest results, necessitating further research for improved therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Early resistance to adefovir during treatment of a chronic hepatitis B].

Virologie (Montrouge, France)·2021
Same author

[The genetic diversity of hepatitis C virus and its implications for pathogenesis and resistance to treatment].

Virologie (Montrouge, France)·2021
Same author

Fatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018
Same author

Detection of Bartonella in cat scratch disease using a single-step PCR assay kit.

Journal of medical microbiology·2017
Same author

Impact on the medical decision-making process of multiplex PCR assay for respiratory pathogens.

Epidemiology and infection·2017
Same author

Diagnosis of community-acquired acute respiratory illness: From conventional microbiological methods to molecular detection (multiplex).

Pathologie-biologie·2015

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Context:

  • Chronic viral hepatitis B, C, and D are significant global health concerns.
  • Long-term consequences include liver cirrhosis and primary liver cancer.
  • Current therapeutic options, such as interferon alpha, offer modest efficacy.

Purpose:

  • To review the current landscape of chronic viral hepatitis treatment.
  • To highlight the limitations and uncertainties associated with existing therapies.
  • To emphasize the need for further clinical and fundamental research.

Summary:

  • Interferon alpha has shown some success but yields modest results in treating chronic viral hepatitis.
  • Significant uncertainties persist regarding optimal treatment protocols, including dosage, duration, and combination therapies with nucleoside analogues.
  • The abundance of clinical studies with conflicting outcomes underscores the need for more research.

Impact:

  • Further multicenter trials are essential to clarify optimal treatment strategies.
  • Continued fundamental research is crucial for developing novel therapeutic molecules.
  • Improved treatment approaches are needed to combat the long-term consequences of viral hepatitis.

Related Experiment Videos